Search
for
Sort by
Research 571–600 of 1000+
- Wound Healing: A Cellular Perspective
- Mechanisms regulating skin immunity and inflammation
- The Dynamics of the Skin’s Immune System
- Skin wound healing in humans and mice: Challenges in translational research
- Severe Acute Respiratory Syndrome Among Children
- Drug-Induced Skin, Nail and Hair Disorders
- Hair Growth Cycle Affects Hair Follicle Destruction by Ruby Laser Pulses
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- What causes hidradenitis suppurativa ?—15 years after
- DRUG‐ASSOCIATED ALOPECIA
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- An Overview of Alopecias
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Shedding: How to manage a common cause of hair loss
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- The Basic Science of Hair Biology
- Alopecia in Association with Malignancy: A Review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Transferosomes: Unique vesicular carriers for effective transdermal delivery
- Hair loss with levetiracetam in five patients with epilepsy
- Isoniazid-induced alopecia
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus